Home
All Journals
Expert Review of Pharmacoeconomics & Outcomes Research
List of Issues
Volume 4, Issue 5

Expert Review of Pharmacoeconomics & Outcomes Research

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 4, Issue 5 (2004)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 4, Issue 5 (2004)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Volume 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Pharmacoeconomic analysis of therapies for pediatric patients

Dennis Raisch, Mark Holdsworth, Patricia Marshik & Heather Campbell

Pages: 483-487

Published online: 09 Jan 2014

First Page PreviewforPharmacoeconomic analysis of therapies for pediatric patients | References | PDF (70.9 KB)

2735 Views
2 CrossRef citations
0Altmetric

Free Access

Bulletin Board

Announcement

News in Brief

Pages: 489-493

Published online: 09 Jan 2014

First Page PreviewforNews in Brief | PDF (76.6 KB)

6 Views
0 CrossRef citations
0Altmetric

Drug Evaluation

Article

Cost-effectiveness of pegylated IFN-α_2b and -_2a and ribavirin for chronic hepatitis C treatment

Ewa Orlewska

Pages: 495-504

Published online: 09 Jan 2014

AbstractforCost-effectiveness of pegylated IFN-α_2b and -_2a and ribavirin for chronic hepatitis C treatment | References | PDF (115.3 KB)

10 Views
1 CrossRef citations
0Altmetric

Article

Idiopathic- and scleroderma-related pulmonary arterial hypertension: outcomes and QOL on bosentan

Anne Keogh & John Wlodarczyk

Pages: 505-513

Published online: 09 Jan 2014

AbstractforIdiopathic- and scleroderma-related pulmonary arterial hypertension: outcomes and QOL on bosentan | References | PDF (106.6 KB)

19 Views
1 CrossRef citations
0Altmetric

Review

Review Article

Half standard deviation estimate of the minimally important difference in HRQOL scores?

Sepideh S Farivar, Honghu Liu & Ron D Hays

Pages: 515-523

Published online: 09 Jan 2014

AbstractforHalf standard deviation estimate of the minimally important difference in HRQOL scores? | References | PDF (88.8 KB)

274 Views
132 CrossRef citations
0Altmetric

Review Article

Prostate cancer and QOL: impact of treatment, disease burden and psychosocial interventions

Frank J Penedo & Jason R Dahn

Pages: 525-535

Published online: 09 Jan 2014

AbstractforProstate cancer and QOL: impact of treatment, disease burden and psychosocial interventions | References | PDF (131 KB)

25 Views
3 CrossRef citations
0Altmetric

Review Article

Cost-effectiveness lessons from disease-modifying drugs in the treatment of multiple sclerosis

Jeffrey S Hoch

Pages: 537-547

Published online: 09 Jan 2014

AbstractforCost-effectiveness lessons from disease-modifying drugs in the treatment of multiple sclerosis | References | PDF (129.4 KB)

25 Views
10 CrossRef citations
0Altmetric

Review Article

Cost–utility of inhaled corticosteroids in patients with moderate-to-severe asthma

Monia Marchetti, Maria Cavallo, Elena Annoni & Simone Gerzeli

Pages: 549-564

Published online: 09 Jan 2014

AbstractforCost–utility of inhaled corticosteroids in patients with moderate-to-severe asthma | References | PDF (146 KB)

34 Views
2 CrossRef citations
0Altmetric

Review Article

Costs of multiple myeloma and associated skeletal-related events in The Netherlands

Martijn T Groot, Peter C Huijgens, Pierre J Wijermans & Carin A Uyl-de Groot

Pages: 565-572

Published online: 09 Jan 2014

AbstractforCosts of multiple myeloma and associated skeletal-related events in The Netherlands | References | PDF (81.4 KB)

53 Views
13 CrossRef citations
0Altmetric

Review Article

Management and costs of severe psoriasis: the role of new biologics

Steven R Feldman & Daniel J Pearce

Pages: 573-579

Published online: 09 Jan 2014

AbstractforManagement and costs of severe psoriasis: the role of new biologics | References | PDF (88.2 KB)

12 Views
3 CrossRef citations
0Altmetric

Miscellaneous

The truly remarkable universality of half a standard deviation: confirmation through another look

Geoffrey R Norman, Jeff A Sloan & Kathleen W Wyrwich

Pages: 581-585

Published online: 09 Jan 2014

AbstractforThe truly remarkable universality of half a standard deviation: confirmation through another look | References | PDF (68.5 KB)

476 Views
373 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore

Cheng Ean Chee et al.

Article | Published online: 22 May 2024

Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review

Sudewi Mukaromah Khoirunnisa et al.

Review Article | Published online: 20 May 2024

Open Access

Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review

Aziz Rezapour et al.

Review Article | Published online: 20 May 2024

Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration

Lada Leyens et al.

Review Article | Published online: 15 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Pharmacoeconomics & Outcomes Research (Vol.4, Iss.5, 2004)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?